If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Update this Profile
Get Updates
185
Followers on Owler
Cyrus
is a designer and developer of molecular modeling toolkit that helps researchers to predict protein structure in human...
Read more
Overview
Competitors
Acquisitions
Funding
News & Insights
Cyrus
is a designer and developer of molecular modeling toolkit that helps researchers to predict protein structure in human...
Read more
Co-Founder & CEO
Lucas Nivon
CEO Approval Rating
92/100
Weigh In
2014
Seattle
Washington
Seattle Metropolitan Area
Private
Pharmaceuticals & Biotechnology
Biotechnology
2836
NAICS listing
http://cyrusbio.com/
Est. Annual Revenue
$5.0-25M
Agree?
Yes
No
Est. Employees
25-100
Agree?
Yes
No
Funding
$29.3M
Acquisitions
1
News
Latest News
Jan 09, 2025
StreetInsider
Press Release: Cyrus : Cyrus Biotechnology Announces Selection of CYR212 as Clinical Candidate for Chronic IgG-driven Autoimmune Disease Including Myasthenia Gravis and Immune Thrombocytopenia
Dec 11, 2024
Business Wire
Press Release: Cyrus : Cyrus Biotechnology Announces Potent in vivo Redosability of an Engineered IdeS Protease for IgG-driven Autoimmune Disease, Demonstrating No Anti-drug Antibodies
Nov 11, 2024
StreetInsider
Press Release: Cyrus : Cyrus Biotechnology to Present its Protein Engineering Capability, Immunogenicity Risk Mitigation, and Best-in-Class IgG Protease Candidate at Hit ID Summit
Oct 10, 2024
StreetInsider
Press Release: Cyrus : Cyrus Biotechnology Congratulates David Baker, 2024 Nobel Laureate in Chemistry and Cyrus Co-Founder
Jun 13, 2024
BioPharma-Reporter
Cyrus: AI-fueled protein design startup spun out from Cyrus Biotechnology
Jun 12, 2024
Yahoo
Cyrus: Cyrus Biotechnology to spin out Levitate Bio for biopharma AI
Jan 15, 2024
Acrofan
Cyrus: Cyrus Biotechnology to Present Its Novel IgG-degrading IdeS Enzyme Development Candidates for Autoimmune Indications at PepTalk Conference in San Dieg
Jun 28, 2022
Cyber News
Cyrus: Biotech startups join AWS and other partners in open&source project to help design new proteins & GeekWire
Dec 27, 2021
PharmaLive
Cyrus: Cyrus Biotechnology's COVID therapeutic lead, ACE2.v2.4, strongly binds and neutralizes SARS-CoV-2 omicron variant
Dec 07, 2021
Citybizlist
Cyrus: Cyrus Biotechnology Announces $18M Financing
Follow and Get Alerts
Cyrus Competitors
1
Follow
2
Follow
3
Follow
4
Follow
5
Follow
6
Follow
7
Follow
8
Follow
9
Follow
10
Follow
Unlock 13 + competitors
Trending Companies